Sorafenib versus hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: a systematic review and meta-analysis-Reference-Cited by-同舟云学术

Sorafenib versus hepatic arterial infusion chemotherapy for advanced hepatocellular carcinoma: a systematic review and meta-analysis

Published:2019-05-07 Issue:9 Volume:49 Page:845-855
ISSN:1465-3621
Container-title:Japanese Journal of Clinical Oncology
language:en
Short-container-title:

Author:

Zhuang Bo-wen¹,Li Wei¹,Xie Xiao-hua¹,Hu Hang-tong¹,Lu Ming-de¹²,Xie Xiao-yan¹

Affiliation:

1. Department of Medical Ultrasonics, Institute of Diagnostic and Interventional Ultrasound, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China

2. Department of Hepatobiliary Surgery, The Affiliated Hospital of Sun Yat-Sen University, Guangzhou, China

Abstract

Our meta-analysis showed hepatic arterial infusion chemotherapy provided better tumor response and survival benefits than Sorafenib for advanced hepatocellular carcinoma and should be recommended as an alternative treatment option.

Funder

National Natural Science Foundation of China

Natural Science Foundation of Guangdong Province

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,General Medicine

Link

http://academic.oup.com/jjco/article-pdf/49/9/845/30150647/hyz069.pdf

Reference40 articles.

1. Hepatocellular carcinoma;Forner;Lancet,2018

2. Evidence-based diagnosis, staging, and treatment of patients with hepatocellular carcinoma;Bruix;Gastroenterology,2016